Hybrid ionizable polymer-lipid mRNA delivery systems for intratumoral immunotherapy Ghent University
Despite the clinical success, a large fraction of patients remains unresponsive to immune checkpoint inhibitors. A growing body of evidence indicates that therapeutic unresponsiveness correlates with a lack of CD8+ T cells infiltration in the tumor microenvironment (TME). As the latter depends on prior innate immune activation and recruitment of dendritic cells, a window of opportunity emerges to re-engineer the TME from a so-called ...